Curium, a world leader in nuclear medicine, today announced that it has signed a long-term agreement to extend its current partnership with NRG I PALLAS for new irradiation services in Petten, Netherlands to produce non-carrier added lutetium-177.
Following a tender procedure, Spanish construction firm FCC Construcción has been contracted to build the Pallas research reactor at the Energy & Health Campus in Petten, the Netherlands.
Minister of Health, Welfare and Sport Ernst Kuipers has confirmed full funding has been allocated for the EUR1.68 billion (USD1.79 billion) estimated public investment required for the Pallas research reactor in Petten, the Netherlands.
Full financing approved for Pallas reactor - Nuclear Engineering International neimagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from neimagazine.com Daily Mail and Mail on Sunday newspapers.